vs
Side-by-side financial comparison of FrontView REIT, Inc. (FVR) and NATIONAL RESEARCH CORP (NRC). Click either name above to swap in a different company.
NATIONAL RESEARCH CORP is the larger business by last-quarter revenue ($35.2M vs $18.2M, roughly 1.9× FrontView REIT, Inc.). NATIONAL RESEARCH CORP runs the higher net margin — 5.1% vs 2.2%, a 2.9% gap on every dollar of revenue. On growth, FrontView REIT, Inc. posted the faster year-over-year revenue change (12.0% vs -4.6%).
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.
FVR vs NRC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.2M | $35.2M |
| Net Profit | $400.0K | $1.8M |
| Gross Margin | — | — |
| Operating Margin | 24.9% | 13.3% |
| Net Margin | 2.2% | 5.1% |
| Revenue YoY | 12.0% | -4.6% |
| Net Profit YoY | — | -72.6% |
| EPS (diluted) | — | $49.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $18.2M | — | ||
| Q4 25 | $16.5M | $35.2M | ||
| Q3 25 | $16.8M | $34.6M | ||
| Q2 25 | $17.6M | $34.0M | ||
| Q1 25 | $16.2M | $33.6M | ||
| Q4 24 | — | $36.9M | ||
| Q3 24 | $14.5M | $35.8M | ||
| Q2 24 | — | $35.0M |
| Q1 26 | $400.0K | — | ||
| Q4 25 | $-4.1M | $1.8M | ||
| Q3 25 | $4.0M | $4.1M | ||
| Q2 25 | $-2.9M | $-106.0K | ||
| Q1 25 | $-833.0K | $5.8M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | $-2.4M | $5.7M | ||
| Q2 24 | — | $6.2M |
| Q1 26 | 24.9% | — | ||
| Q4 25 | — | 13.3% | ||
| Q3 25 | — | 22.4% | ||
| Q2 25 | — | 4.7% | ||
| Q1 25 | — | 25.6% | ||
| Q4 24 | — | 26.0% | ||
| Q3 24 | — | 22.3% | ||
| Q2 24 | — | 25.3% |
| Q1 26 | 2.2% | — | ||
| Q4 25 | -24.9% | 5.1% | ||
| Q3 25 | 23.9% | 11.9% | ||
| Q2 25 | -16.5% | -0.3% | ||
| Q1 25 | -5.1% | 17.2% | ||
| Q4 24 | — | 17.8% | ||
| Q3 24 | -16.7% | 15.9% | ||
| Q2 24 | — | 17.6% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.19 | $49.58 | ||
| Q3 25 | $0.19 | $0.18 | ||
| Q2 25 | $-0.16 | $-0.01 | ||
| Q1 25 | $-0.06 | $0.25 | ||
| Q4 24 | — | $0.27 | ||
| Q3 24 | — | $0.24 | ||
| Q2 24 | — | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.3M | $4.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $514.2M | $14.0M |
| Total Assets | $869.8M | $134.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $9.3M | — | ||
| Q4 25 | $13.5M | $4.1M | ||
| Q3 25 | $19.6M | $2.2M | ||
| Q2 25 | $8.4M | $5.3M | ||
| Q1 25 | $3.3M | $2.5M | ||
| Q4 24 | — | $4.2M | ||
| Q3 24 | — | $3.5M | ||
| Q2 24 | — | $485.0K |
| Q1 26 | — | — | ||
| Q4 25 | $314.3M | — | ||
| Q3 25 | $307.1M | — | ||
| Q2 25 | $316.9M | — | ||
| Q1 25 | $310.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $48.7M | ||
| Q2 24 | — | $33.3M |
| Q1 26 | $514.2M | — | ||
| Q4 25 | $391.2M | $14.0M | ||
| Q3 25 | $385.2M | $14.3M | ||
| Q2 25 | $369.9M | $21.3M | ||
| Q1 25 | $324.7M | $29.7M | ||
| Q4 24 | — | $31.3M | ||
| Q3 24 | $1.0K | $34.6M | ||
| Q2 24 | — | $40.2M |
| Q1 26 | $869.8M | — | ||
| Q4 25 | $854.4M | $134.9M | ||
| Q3 25 | $846.8M | $135.7M | ||
| Q2 25 | $856.5M | $141.4M | ||
| Q1 25 | $860.8M | $135.2M | ||
| Q4 24 | — | $132.5M | ||
| Q3 24 | $1.0K | $131.8M | ||
| Q2 24 | — | $119.1M |
| Q1 26 | — | — | ||
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.80× | — | ||
| Q2 25 | 0.86× | — | ||
| Q1 25 | 0.96× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | — | 0.83× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $7.2M |
| Free Cash FlowOCF − Capex | — | $6.1M |
| FCF MarginFCF / Revenue | — | 17.2% |
| Capex IntensityCapex / Revenue | — | 3.2% |
| Cash ConversionOCF / Net Profit | — | 3.99× |
| TTM Free Cash FlowTrailing 4 quarters | — | $15.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $42.1M | $7.2M | ||
| Q3 25 | $8.3M | $13.8M | ||
| Q2 25 | $9.3M | $-1.1M | ||
| Q1 25 | $8.1M | $6.6M | ||
| Q4 24 | — | $6.4M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | $6.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $6.1M | ||
| Q3 25 | — | $10.2M | ||
| Q2 25 | — | $-4.1M | ||
| Q1 25 | — | $3.7M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | $7.8M | ||
| Q2 24 | — | $1.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 17.2% | ||
| Q3 25 | — | 29.4% | ||
| Q2 25 | — | -12.2% | ||
| Q1 25 | — | 10.9% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | 4.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.2% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | — | 8.8% | ||
| Q1 25 | — | 8.9% | ||
| Q4 24 | — | 12.0% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 15.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.99× | ||
| Q3 25 | 2.06× | 3.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.15× | ||
| Q4 24 | — | 0.97× | ||
| Q3 24 | — | 1.66× | ||
| Q2 24 | — | 1.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
